Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation
2019 · Nature Medicine · 395 citations
https://doi.org/10.1038/s41591-019-0400-z
R
Raynier Devillier
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
219
Papers
3.3K
Citations
32
h-index
67
i10-index
Raynier Devillier is an academic researcher from Centre National de la Recherche Scientifique. The author has contributed to research in topics: Hematopoietic Stem Cell Transplantation & Acute Myeloid Leukemia Research & Acute Lymphoblastic Leukemia research. The author has an h-index of 32, co-authored 187 publications.
ORCID: 0000-0002-4045-8310Papers by this author
worksEndowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing
2022 · Nature Communications · 142 citations
https://doi.org/10.1038/s41467-022-30896-2
Haploidentical T Cell–Replete Transplantation with Post-Transplantation Cyclophosphamide for Patients in or above the Sixth Decade of Age Compared with Allogeneic Hematopoietic Stem Cell Transplantation from an Human Leukocyte Antigen–Matched Related or Unrelated Donor
2015 · Biology of Blood and Marrow Transplantation · 88 citations
https://doi.org/10.1016/j.bbmt.2015.08.029
Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio
2016 · Leukemia · 65 citations
https://doi.org/10.1038/leu.2016.183
Manufacturing Natural Killer Cells as Medicinal Products
2016 · Frontiers in Immunology · 41 citations
https://doi.org/10.3389/fimmu.2016.00504
Constitutive AKT activation in follicular lymphoma
2014 · BMC Cancer · 22 citations
https://doi.org/10.1186/1471-2407-14-565
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat